Larimar Therapeutics (LRMR) Profit After Tax (2016 - 2020)
Historic Profit After Tax for Larimar Therapeutics (LRMR) over the last 7 years, with Q1 2020 value amounting to -$3.6 million.
- Larimar Therapeutics' Profit After Tax rose 7255.95% to -$3.6 million in Q1 2020 from the same period last year, while for Mar 2020 it was -$35.9 million, marking a year-over-year increase of 3867.13%. This contributed to the annual value of -$45.4 million for FY2019, which is 2601.03% up from last year.
- Larimar Therapeutics' Profit After Tax amounted to -$3.6 million in Q1 2020, which was up 7255.95% from -$7.3 million recorded in Q4 2019.
- In the past 5 years, Larimar Therapeutics' Profit After Tax ranged from a high of -$3.6 million in Q1 2020 and a low of -$17.7 million during Q1 2016
- For the 5-year period, Larimar Therapeutics' Profit After Tax averaged around -$13.0 million, with its median value being -$13.1 million (2019).
- In the last 5 years, Larimar Therapeutics' Profit After Tax crashed by 3165.08% in 2016 and then surged by 7255.95% in 2020.
- Larimar Therapeutics' Profit After Tax (Quarter) stood at -$10.4 million in 2016, then decreased by 25.35% to -$13.1 million in 2017, then decreased by 11.35% to -$14.6 million in 2018, then skyrocketed by 50.23% to -$7.3 million in 2019, then skyrocketed by 50.38% to -$3.6 million in 2020.
- Its Profit After Tax stands at -$3.6 million for Q1 2020, versus -$7.3 million for Q4 2019 and -$12.9 million for Q3 2019.